Skip to content

Effect of Different Root Canal Sealers on Oxidative Stress Markers

Evaluation of Oxidative Stress in Patients With Chronic Apical Periodontitis Treated With Single Session Root Canal Treatment Using Different Root Canal Sealers: in Vivo Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07059481
Enrollment
40
Registered
2025-07-10
Start date
2024-03-18
Completion date
2025-11-13
Last updated
2025-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Apical Periodontitis, Oxidative Stress

Keywords

oxidative stress, root canal sealers, chronic apical periodontitis, periapical index, total oxidant status, total antioxidant status, oxidative stress index, 8-epi, malondialdehyde, myeloperoxidase

Brief summary

The goal of this clinical trial is to primary purpose investigate and compare oxidative stress markers in patients with chronic apical periodontitis treated with different root canal paste in a single session. The main questions it aims to answer are: Is there a change in oxidative stress markers measured from saliva after root canal treatment? Is there a difference between the change of oxidative stress markers in patients using different root canal sealers after root canal treatment? Researchers will compare bioceramic-based and epoxy resin-based root canal sealers to see if there are significant differences in oxidative stress markers measured from patients' saliva after root canal treatment. * Participants will be informed about all procedures before starting the clinical process. * Participants are expected to allow saliva sampling two times: first sample will be collected on root canal treatment session and second sample will be collected on the 30th day after root canal treatment. * Participants will be informed in writing about the treatment procedure before starting the clinical process. * Participants are expected to sign the informed consent form on a voluntary basis.

Interventions

OTHERRoot Canal Treatment and Sample Collection

Single session root canal treatment procedure will be performed with VDW Gold Reciproc device and reciprocal files (Endo T-Must, Dentac, Turkey). Endodontium Samples will be collected from each patient's root canal, with 15 Hedström files (Dentsplay).

DIAGNOSTIC_TESTPAI Score Comparasion

PAI scores of the patients will be determined with periapical films taken before treatment and compared with oxidative stress markers before and after treatment for the epoxyamine group and bioceramic group.

Sponsors

bengi gülgü
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The root canal paste to be used will be selected from identical black envelopes by another physician who will not participate in the treatment.

Intervention model description

the results obtained from the groups will be compared and correlated both within and between the groups.

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Systemically healthy, ASA1 patients, * Phase 1 periodontal treatment was performed, * Diagnosed with chronic apical periodontitis in a single tooth with 2 or more roots in the mouth, * The lesion measured \<2 cm on radiographic evaluation, * The vitality of the tooth was checked by EPT (Ai-Pex, Woodpecker, China) and Cold test (Cerkamed, Poland) and confirmed to be devitalised, * Socioculturally able to participate in the treatment, * Individuals who did not smoke or drink alcohol

Exclusion criteria

* Patients who have used antibiotics in the last three months and analgesics in the last two weeks * Patients who smoke and/or abuse alcohol * Patients younger than 18 years or older than 45 years, * Patients with controlled or uncontrolled systemic disease and life-threatening conditions (ASA 2,3,4,5,6) * Pregnant or lactating women, * Patients with poor oral hygiene, * Patients who had head and neck radiotherapy, * With obesity, * Active periodontal disease, * Periodontal pocket depth over 3mm, * There is enough loss of material in the relevant tooth to prevent adequate isolation or to require post placement, * Clinical examination of the relevant tooth showing symptoms in percussion-palpation, * Radiographically, the lesion is seen in relation to anatomical formations such as the mandibular canal and maxillary sinus, * Patients who required prophylactic antibiotic use before invasive dental procedures were excluded from the study. * Patients who did not attend the follow-up appointment and patients who experienced complications during expansion (instrument seperation, perforation, etc.) were excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Changes in biochemically measured oxidative stress markers at 30th day in patients treated with epoxyamine/bioceramic root canal pastes.three month aproximatelyoxidative stress markers (myeloperoxidase, 8-epi, total oxidant status, total antioxidant status, oxidative stress index, malondialdehyde) will be measured and compared biochemically in saliva samples taken from the patients on the first and thirtieth day.
Comparison of the changes observed in biochemically measured oxidative stress markers of patients in the bioceramic group and patients in the epoxyamine group at day 1 and day 30three month aproximatelyresults of oxidative stress measurement obtained from bioceramic group and epoxyamin group will be compared. comparsion will be performed with biochemical kits for saliva samples.

Secondary

MeasureTime frameDescription
Investigation of the relationship between biochemically measured oxidative stress markers from endodontium and initial saliva samples obtained from all patients and PAI score determined by periapical filmsthree months aproximatelyresults of PAI and oxidative stress markers measured with biochemical kits will be compromised.

Countries

Turkey (Türkiye)

Contacts

Primary ContactBengi Gülgü
bengigulgu@gmail.com+905330262002

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026